I am excited to share two new reports that provide a comprehensive overview of Lilly’s corporate responsibility efforts. The reports highlight how we are evolving our approach to corporate responsibility by increasingly leveraging our assets and capabilities to have greater, more sustainable impact.
The 2014 Corporate Responsibility Update offers a thorough look at our progress on numerous fronts, including charitable contributions, philanthropic initiatives, global health efforts, environmental performance, ethics and compliance, and more. The 2015 Global Health Programs Report details the work that Lilly and its nearly 50 partners have undertaken through our two signature global health programs—the Lilly MDR-TB Partnership for multidrug-resistant tuberculosis, and the Lilly NCD Partnership for non-communicable diseases, with a focus on diabetes.
Our Corporate Responsibility Update also serves as Lilly's communication to the United Nations Global Compact (UNGC). As a signatory of the UNGC, Lilly shares its progress annual on 10 widely accepted principles related to human rights, labor, the environment, and anti-corruption.